Background/Aims: Klotho is required for the inhibitory effect of FGF23 on 1,25(OH)2D3 formation and Klotho-hypomorphic mice (kl/kl) suffer from severe tissue calcification due to excessive 1,25(OH)2D3 formation with subsequent increase of Ca2+ and phosphate concentrations and stimulation of osteogenic signaling. The excessive tissue calcification dramatically accelerates aging and leads to premature death of the animals. Osteogenic signaling in those mice is disrupted by treatment with NH4Cl, which prevents tissue calcification and early death of kl/kl mice. The present study explored whether the beneficial effects of NH4Cl treatment could be mimicked by NH4NO3 treatment. Methods: The kl/kl mice had free access to tap water either without or with addition of NH4NO3 (0.28 M) starting with the mating of the parental generation. Calcification of trachea, lung, kidney, stomach, heart and vessels was visualized by histology with von Kossa staining. Plasma phosphate concentration was determined utilizing photometry, blood gas and electrolytes utilizing a blood Gas and Chemistry Analysis System and plasma 1,25(OH)2D3 concentration with ELISA. Results: In untreated kl/kl mice plasma 1,25(OH)2D3 and phosphate concentrations were elevated, and the mice suffered from marked calcification of all tissues analyzed. Untreated kl/kl mice further suffered from respiratory acidosis due to marked lung emphysema. NH4NO3-treatment decreased both, blood pCO2 and HCO3-, decreased calcification of trachea, lung, kidney, stomach, heart and vessels and increased the life span of kl/kl mice more than 1.7-fold (♂) or 1.6-fold (♀) without significantly affecting extracellular pH or plasma concentrations of 1,25(OH)2D3, Ca2+, phosphate, Na+, and K+. Conclusions: NH4NO3-treatment turns respiratory acidosis into metabolic acidosis and mitigates calcification thus leading to a substantial extension of kl/kl mice survival.

The protein klotho is required for the inhibitory effect of FGF23 on 25-hydroxyvitamin D3 1-α-hydroxylase (1-α-hydroxylase) and thus 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) production [1]. Klotho may further up-regulate renal epithelial Ca2+ channels [2] and down-regulate renal tubular phosphate transport [3]. Klotho-hypomorphic mice (kl/kl) suffer from severe tissue calcification leading to profound growth deficit, premature appearance of several age related disorders and dramatic shortening of life span [1,4]. Conversely, murine life span is extended by klotho overexpression [5]. In humans, klotho gene variants similarly impact on ageing and life span [6].

Chronic kidney disease (CKD) similarly leads to tissue calcification [7] with negative impact on life span [8]. In CKD tissue calcification is primarily a consequence of impaired phosphate excretion but is compounded by klotho deficiency [9] and affected by a klotho gene variant [10]. Vascular calcification is driven by an active pathophysiological process [11] with transition of vascular smooth muscle cells into an osteo- and chondrogenic phenotypes [12]. Osteogenic reprogramming is stimulated by hyperphosphatemia [13] and hyperaldosteronism [14].

CKD patients and kl/kl mice further suffer from acidosis [15,16], which may counteract CaHPO4 precipitation [17,18]. Along those lines, tissue calcification of kl/kl mice could be prevented by induction of acidosis with acetazolamide [18]. In theory the acidosis could be aggravated by NH4+ intake [19,20]. NH4+ may further dissociate to H+ and the cell membrane permeable NH3, which enters acidic compartments [21], binds H+ and is thus trapped as NH4+ in those compartments [22] H+ binding of NH3 is followed by alkalinization of the acidic cellular compartments [23].

Treatment of kl/kl mice with NH4Cl halts tissue calcification and thus leads to reversal of growth deficit and marked increase of life span [24], effects attributed in large part to disruption of osteogenic signaling due to alkalinization of acidic cellular compartments [24]. The present study explored whether NH4NO3 is similarly able to favorably influence tissue calcification and survival of kl/kl mice.

Mice

All animal experiments were conducted according to German law for the welfare of animals and were approved by local authorities. Male and female klotho-hypomorphic mice (kl/kl) were compared to male and female wild-type mice (WT). The origin of the mice, breeding and genotyping were described previously [4]. The mice had access to either tap water or a solution of NH4NO3 (0.28 M) in tap water ad libitum and were fed a standard chow diet (Sniff, Soest, Germany). The NH4NO3 treatment started with the mating of the parental generation and was maintained from pregnancy and weaning until analysis of the mice. The offspring was separated from the mothers at the age of four weeks.

Blood and urinary chemistry

To obtain blood specimens, animals were lightly anesthetized and about 50 - 200 µl of blood was withdrawn into heparinized capillaries by puncturing the retro-orbital plexus. The plasma phosphate concentrations were determined utilizing a photometric method (FUJI FDC 3500i, Sysmex, Norsted, Germany). Blood gas and electrolyte analysis as well as the measurement of ionized calcium was performed with the EDAN i15 Blood Gas and Chemistry Analysis System (EDAN Instruments, Shenzen, China). An ELISA kit was employed to determine plasma 1,25(OH)-vitamin D3 concentration (IDS, Boldon, UK) [25].

Histology

For histological analysis of trachea, lung, kidney, stomach, heart and vessels, tissues from male kl/kl mice (age 8 weeks) with or without treatment with NH4NO3 (0.28 M in drinking water) were embedded in paraffin, cut in 2-3 µm sections and stained with hematoxylin and eosin (H&E) and von Kossa [26].

Statistics

Data are provided as means ± SEM, n represents the number of independent experiments. All data were tested for significance using ANOVA followed by posthoc analysis. For the life span experiments, SAS Jmp version 8.0.1 (SAS Institute Inc., Cary, NC, USA) was used. Only results with p < 0.05 were considered statistically significant.

The present study explored whether NH4NO3 treatment (0.28 M in tap water) influenced growth deficit, tissue calcification and survival of klotho-hypomorphic (kl/kl) mice. As shown in Fig. 1A, kl/kl mice were markedly smaller than corresponding wild-type mice (WT). Accordingly, the body weight was significantly less in kl/kl mice than in wild-type mice (Fig. 1B). Following NH4NO3 treatment (0.28 M in tap water), the body weight of kl/kl mice was significantly increased. Following NH4NO3 treatment the body weight was thus not significantly different between kl/kl mice and wild-type mice.

Fig. 1

Effect of NH4NO3 treatment on body weight of kl/kl mice. A. Photograph of wild-type mice (WT) as well as klotho-hypomorphic mice (kl/kl) without (left) and with (right) NH4NO3 treatment (0.28 M in tap water). B. Arithmetic means ± SEM (n = 5-9) of body weight of wild-type mice (WT, white bars) and klotho-hypomorphic mice (kl/kl, black bars) without (Control, left bars) and with (NH4NO3, right bars) NH4NO3 treatment (0.28 M in tap water). *(p < 0.05) indicates statistically significant differences from respective WT mice; ##(p < 0.01) indicates statistically significant differences from respective untreated mice.

Fig. 1

Effect of NH4NO3 treatment on body weight of kl/kl mice. A. Photograph of wild-type mice (WT) as well as klotho-hypomorphic mice (kl/kl) without (left) and with (right) NH4NO3 treatment (0.28 M in tap water). B. Arithmetic means ± SEM (n = 5-9) of body weight of wild-type mice (WT, white bars) and klotho-hypomorphic mice (kl/kl, black bars) without (Control, left bars) and with (NH4NO3, right bars) NH4NO3 treatment (0.28 M in tap water). *(p < 0.05) indicates statistically significant differences from respective WT mice; ##(p < 0.01) indicates statistically significant differences from respective untreated mice.

Close modal

As illustrated in Fig. 2A, plasma 1,25(OH)2D3 concentration was significantly higher in kl/kl mice than in wild-type mice, a difference not significantly affected by NH4NO3 treatment. Similarly, plasma phosphate concentration was significantly higher in kl/kl mice than in wild-type mice, a difference again not significantly affected by treatment with NH4NO3 (Fig. 2B). Blood ionized Ca2+ was again significantly higher in untreated kl/kl mice than in untreated wild-type mice, a difference again not significantly modified by NH4NO3 treatment (Fig. 2C). There were no differences in blood Na+ levels (Fig. 2D) between kl/kl mice and wild-type mice and between untreated and NH4NO3 treated animals. Plasma K+ concentration was significantly lower in untreated kl/kl mice than in untreated wild-type mice (Fig. 2E), a difference abolished by NH4NO3 treatment. There were no differences in blood Cl- concentrations between kl/kl mice and wild-type mice (Fig. 2F). NH4NO3 treatment significantly increased blood Cl- concentrations in both, kl/kl mice and wild-type mice (Fig. 2F).

Fig. 2

Plasma 1,25(OH)2D3, phosphate, Ca2+, Na+, K+, and Cl- concentrations of wild-type mice and kl/kl mice with or without NH4NO3 treatment. Arithmetic means ± SEM of plasma (A) 1,25(OH)2D3 (n = 7), (B) phosphate (n = 4-9), (C) ionized Ca2+ (n = 10), (D) Na+ (n = 10), (E) K+ (n = 10), and (F) Cl- (n = 10) concentrations of wild type mice (WT, white bars) and klotho-hypomorphic mice (kl/kl, black bars) without (Control, left bars) and with (NH4NO3, right bars) NH4NO3 treatment (0.28 M in tap water). *( p < 0.05), **( p < 0.01) indicate statistically significant differences from respective WT mice; ###( p < 0.001) indicate statistically significant differences from respective untreated mice.

Fig. 2

Plasma 1,25(OH)2D3, phosphate, Ca2+, Na+, K+, and Cl- concentrations of wild-type mice and kl/kl mice with or without NH4NO3 treatment. Arithmetic means ± SEM of plasma (A) 1,25(OH)2D3 (n = 7), (B) phosphate (n = 4-9), (C) ionized Ca2+ (n = 10), (D) Na+ (n = 10), (E) K+ (n = 10), and (F) Cl- (n = 10) concentrations of wild type mice (WT, white bars) and klotho-hypomorphic mice (kl/kl, black bars) without (Control, left bars) and with (NH4NO3, right bars) NH4NO3 treatment (0.28 M in tap water). *( p < 0.05), **( p < 0.01) indicate statistically significant differences from respective WT mice; ###( p < 0.001) indicate statistically significant differences from respective untreated mice.

Close modal

As illustrated in Fig. 3A, blood pH was lower in untreated kl/kl mice than in untreated wild-type mice. NH4NO3 treatment significantly decreased blood pH in wild-type mice. NH4NO3 treatment tended to decrease blood pH in kl/kl mice, an effect, however, not reaching statistical significance (Fig. 3A). As shown in Fig. 3B, blood pCO2 was significantly increased in kl/kl mice and significantly decreased to normal values under treatment with NH4NO3. Plasma HCO3- concentration was significantly higher in untreated kl/kl mice than in untreated wild-type mice, a difference again significantly blunted by NH4NO3 treatment (Fig. 3 C,D).

Fig. 3

Blood pH, pCO2, HCO3- act. and HCO3- std. concentrations of wild-type mice and kl/kl mice with or without NH4NO3 treatment. Arithmetic means ± SEM (n = 10) of blood (A) pH, (B) pCO2, (C) actual HCO3- and (D) HCO3- standardized to normal CO2, in wild-type mice (WT, white bars) and klotho-hypomorphic mice (kl/kl, black bars) without (Control, left bars) and with (NH4NO3, right bars) NH4NO3 treatment (0.28 M in tap water). *(p < 0.05), **(p < 0.01) indicate statistically significant differences from respective WT mice; #( p < 0.05), ##( p < 0.01) indicate statistically significant differences from respective untreated mice.

Fig. 3

Blood pH, pCO2, HCO3- act. and HCO3- std. concentrations of wild-type mice and kl/kl mice with or without NH4NO3 treatment. Arithmetic means ± SEM (n = 10) of blood (A) pH, (B) pCO2, (C) actual HCO3- and (D) HCO3- standardized to normal CO2, in wild-type mice (WT, white bars) and klotho-hypomorphic mice (kl/kl, black bars) without (Control, left bars) and with (NH4NO3, right bars) NH4NO3 treatment (0.28 M in tap water). *(p < 0.05), **(p < 0.01) indicate statistically significant differences from respective WT mice; #( p < 0.05), ##( p < 0.01) indicate statistically significant differences from respective untreated mice.

Close modal

Histology was employed to visualize tissue calcification and histopathology in untreated and NH4NO3 treated male kl/kl mice. As illustrated in Fig. 4, excessive calcification was observed in trachea, lung, kidney, and stomach of kl/kl mice. Moreover, histology revealed marked emphysema of lung tissue from kl/kl mice. NH4NO3 treatment strongly reduced the tissue calcification and reversed the emphysema of kl/kl mice. As shown in Fig. 5, excessive calcifications were similarly observed in cardiac and vascular tissue of untreated kl/kl mice. Again, NH4NO3 treatment blunted the calcification of cardiac and vascular tissue from kl/kl mice.

Fig. 4

NH4NO3 treatment counteracts soft tissue calcification in kl/kl mice. H&E and von Kossa staining of trachea, lung, kidney, and stomach from male klotho-hypomorphic mice without (untreated, upper panel) and with (treated, lower panel) NH4NO3 treatment (0.28 M in tap water). The results are representative for three kl/kl mice per group. Arrowheads indicate the calcifications; Asterisk indicates the cartilage.

Fig. 4

NH4NO3 treatment counteracts soft tissue calcification in kl/kl mice. H&E and von Kossa staining of trachea, lung, kidney, and stomach from male klotho-hypomorphic mice without (untreated, upper panel) and with (treated, lower panel) NH4NO3 treatment (0.28 M in tap water). The results are representative for three kl/kl mice per group. Arrowheads indicate the calcifications; Asterisk indicates the cartilage.

Close modal
Fig. 5

NH4NO3 treatment counteracts cardiac and vascular calcification in kl/kl mice. H&E and von Kossa staining of cardiac and vascular tissue from male klotho-hypomorphic mice without (untreated, upper panel) and with (treated, lower panel) NH4NO3 treatment (0.28 M in tap water). The results are representative for three kl/kl mice per group.

Fig. 5

NH4NO3 treatment counteracts cardiac and vascular calcification in kl/kl mice. H&E and von Kossa staining of cardiac and vascular tissue from male klotho-hypomorphic mice without (untreated, upper panel) and with (treated, lower panel) NH4NO3 treatment (0.28 M in tap water). The results are representative for three kl/kl mice per group.

Close modal

As illustrated in Fig. 6, NH4NO3 treatment was followed by a substantial and significant (Log-Rang p < 0.0004; Wilcoxon p < 0.0016) increase of the life span of male kl/kl mice. Half of untreated kl/kl mice survived 72 days and half of the NH4NO3 treated kl/kl mice survived 122 days. Accordingly, NH4NO3 treatment extended the median life span of kl/kl mice by a factor of 1.7.

Fig. 6

Effect of NH4NO3 on life span of kl/kl mice. Percentage of surviving male klotho-hypomorphic mice (kl/kl) maintained on control diet without treatment (closed circles) and with NH4NO3 treatment (0.28 M in tap water, open circles) as a function of age. Survival of kl/kl mice was significantly extended by NH4NO3 treatment (Log-Rang (p < 0.0004, Wilcoxon p < 0.0016; n = 7 - 9).

Fig. 6

Effect of NH4NO3 on life span of kl/kl mice. Percentage of surviving male klotho-hypomorphic mice (kl/kl) maintained on control diet without treatment (closed circles) and with NH4NO3 treatment (0.28 M in tap water, open circles) as a function of age. Survival of kl/kl mice was significantly extended by NH4NO3 treatment (Log-Rang (p < 0.0004, Wilcoxon p < 0.0016; n = 7 - 9).

Close modal

The present study confirms the phenotype of kl/kl mice, i.e. the severe tissue calcification, growth deficit and accelerated aging presumably resulting from unrestricted formation of 1,25(OH)2D3 with subsequent marked increase of Ca2+ and phosphate concentrations leading to triggering of osteogenic signaling [1]. The present study further reveals that NH4NO3 treatment mitigates tissue calcification of kl/kl mice, leading to almost complete reversal of growth deficit, attenuation of tissue injury and substantial extension of life span. All those effects mimic those of NH4Cl treatment, which has previously been shown to disrupt the excessive osteogenic signaling of kl/kl mice [24].

The tissue calcification of kl/kl mice is most likely due to excessive extracellular phosphate concentrations, which are known to stimulate osteogenic signaling and vascular calcification [13], which is in turn a hallmark of aging [7,27,28,29]. Along those lines plasma phosphate concentration is a determinant of mortality [30]. NH4NO3 treatment mitigates tissue calcification in kl/kl mice without significantly modifying plasma 1,25(OH)2D3, Ca2+ and phosphate concentrations. NH4NO3 treatment is further effective despite virtually constant extracellular pH, another determinant of calcification [18,31,32,33].

NH4NO3 treatment does not aggravate the acidosis of kl/kl mice, which is due to excessive pCO2 presumably due to the severe lung emphysema (Fig. 4). The NH4NO3 treatment reverses the hypercapnia presumably by counteracting the development of lung emphysema (Fig. 4). At the same time, however, NH4NO3 treatment decreases plasma bicarbonate concentration, presumably due to partial incorporation of NH4+ into urea, a metabolic pathway consuming HCO3-[34]. Following NH4NO3 treatment bicarbonate and pCO2 decline in parallel leaving extracellular pH virtually unchanged. Accordingly, NH4NO3 treatment converts the respiratory acidosis of untreated kl/kl mice into a metabolic acidosis.

Similar to the excessive osteogenic signaling in kl/kl mice [24,35], enhanced osteogenic signaling leads to vascular calcification in CKD patients [35,36]. In CKD vascular calcification increases the risk for cardiovascular events [37], the leading cause of death in this clinical condition [38]. Similar to the osteogenic signaling in kl/kl mice, osteogenic signaling in CKD patients [39] is secondary to hyperphosphatemia and is compounded by decrease of klotho expression [35]. Disruption of osteogenic reprogramming in vascular tissue is thus expected to favourably influence the clinical course of CKD [39].

Treatment with NH4NO3 decreases tissue and vascular calcification, reverses the growth deficit and substantially extends the life span of klotho-hypomorphic mice despite continued increase of plasma 1,25(OH)2D3, Ca2+ and phosphate concentrations. In view of the previous observations following NH4Cl treatment, NH4NO3 treatment is presumably effective by disrupting osteogenic signaling.

The authors state that they do not have any conflicts of interest to disclose.

The authors acknowledge the technical assistance of Dennis Thiele, Elfriede Faber and the meticulous preparation of the manuscript by Tanja Loch. The study was supported by the Deutsche Forschungsgemeinschaft (DFG 315/15-1).

1.
Kuro-o M: Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol 2013;9:650-660.
2.
Topala CN, Bindels RJ, Hoenderop JG: Regulation of the epithelial calcium channel TRPV5 by extracellular factors. Curr. Opin. Nephrol. Hypertens 2007;16:319-324.
3.
Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW: Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010;24:3438-3450.
4.
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51.
5.
Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M: Suppression of aging in mice by the hormone Klotho. Science 2005;309:1829-1833.
6.
Invidia L, Salvioli S, Altilia S, Pierini M, Panourgia MP, Monti D, De Rango F, Passarino G, Franceschi C: The frequency of Klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect. Biogerontology 2010;11:67-73.
7.
Shroff R, Long DA, Shanahan C: Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 2013;24:179-189.
8.
Staude H, Jeske S, Schmitz K, Warncke G, Fischer DC: Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease. Kidney Blood Press Res 2013;37:68-83.
9.
Hu MC, Kuro-o M, Moe OW: The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant 2012;27:2650-2657.
10.
Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R: Klotho variants and chronic hemodialysis mortality. J Bone Miner Res 2009;24:1847-1855.
11.
Mizobuchi M, Towler D, Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009;20:1453-1464.
12.
Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-1154.
13.
Giachelli CM: Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003;14:S300-S304.
14.
Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro-o M, Lang F: Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 2013;123:812-822.
15.
Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BC, van Leeuwen JP, Bindels RJ, Hoenderop JG: Klotho prevents renal calcium loss. J Am Soc Nephrol 2009;20:2371-2379.
16.
Kovesdy CP: Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Nephrol Dial Transplant 2012;27:3056-3062.
17.
Yonova D: Vascular calcification and metabolic acidosis in end stage renal disease. Hippokratia 2009;13:139-140.
18.
Leibrock CB, Alesutan I, Voelkl J, Michael D, Castor T, Kohlhofer U, Quintanilla-Martinez L, Kubler L, Mannheim JG, Pichler BJ, Rosenblatt KP, Kuro-o M, Lang F: Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice. J Mol Med (Berl) 2016;94:95-106.
19.
Nowik M, Kampik NB, Mihailova M, Eladari D, Wagner CA: Induction of metabolic acidosis with ammonium chloride (NH4Cl) in mice and rats-species differences and technical considerations. Cell Physiol Biochem 2010;26:1059-1072.
20.
Mohebbi N, Perna A, van der Wijst J, Becker HM, Capasso G, Wagner CA: Regulation of two renal chloride transporters, AE1 and pendrin, by electrolytes and aldosterone. PLoS One 2013;8:e55286.
21.
Roos A, Boron WF: Intracellular pH. Physiol Rev 1981;61:296-434.
22.
Ling H, Ardjomand P, Samvakas S, Simm A, Busch GL, Lang F, Sebekova K, Heidland A: Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int 1998;53:1706-1712.
23.
Volkl H, Friedrich F, Haussinger D, Lang F: Effect of cell volume on Acridine Orange fluorescence in hepatocytes. Biochem J 1993;295:11-14.
24.
Leibrock CB, Alesutan I, Voelkl J, Pakladok T, Michael D, Schleicher E, Kamyabi-Moghaddam Z, Quintanilla-Martinez L, Kuro-o M, Lang F: NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency. J Am Soc Nephrol 2015;26:2423-2433.
25.
Feger M, Mia S, Pakladok T, Nicolay JP, Alesutan I, Schneider SW, Voelkl J, Lang F: Down-regulation of renal klotho expression by Shiga toxin 2. Kidney Blood Press Res 2014;39:441-449.
26.
Mossbrugger I, Hoelzlwimmer G, Calzada-Wack J, Quintanilla-Martinez L: Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic. Verh Dtsch Ges Pathol 2007;91:98-103.
27.
Kapustin A, Shanahan CM: Targeting vascular calcification: softening-up a hard target. Curr Opin Pharmacol 2009;9:84-89.
28.
Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010;5:S23-S30.
29.
Weissen-Plenz G, Nitschke Y, Rutsch F: Mechanisms of arterial calcification: spotlight on the inhibitors. Adv Clin Chem 2008;46:263-293.
30.
Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005;112:2627-2633.
31.
Jara A, Felsenfeld AJ, Bover J, Kleeman CR: Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease. Kidney Int 2000;58:1023-1032.
32.
Mendoza FJ, Lopez I, Montes dO, Perez J, Rodriguez M, Aguilera-Tejero E: Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 2008;73:407-414.
33.
Jara A, Chacon C, Ibaceta M, Valdivieso A, Felsenfeld AJ: Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes. Nephrol Dial Transplant 2004;19:1986-1992.
34.
Guder WG, Haussinger D, Gerok W: Renal and hepatic nitrogen metabolism in systemic acid base regulation. J Clin Chem Clin Biochem 1987;25:457-466.
35.
Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW: Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011;22:124-136.
36.
Moe SM, Drueke T, Lameire N, Eknoyan G: Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 2007;14:3-12.
37.
London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
38.
Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
39.
Koleganova N, Piecha G, Ritz E, Schirmacher P, Muller A, Meyer HP, Gross ML: Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2009;24:2488-2496.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.